GSK - VIIV HEALTHCARE WILL INITIATE SUBMISSIONS OF CABOTEGRAVIR LONG-ACTING FOR PREP TO OTHER REGULATORY AUTHORITIES BY END OF 2021
Stock Market News in real time
- Stock Market
- Stock Market News in real time
- Economy
- Gsk - Viiv Healthcare Will Initiate Submissions Of Cabotegravir Long-Acting For Prep To Other Regulatory Authorities By End Of 2021